# Protalix Biotherapeutics (NYSE: PLX), Karmiel, Israel – FDA Inspections

Source: https://www.keypedia.com/companies/protalix-biotherapeutics/7c95faf3-0d7f-4c96-8fb3-ed4b7c4c5fdd

> Inspection records and compliance data for Protalix Biotherapeutics in Karmiel. 1 FDA inspection on record, last inspected November 11, 2010. Publicly traded as NYSE: PLX.

---

## Details

- Name: Protalix Biotherapeutics
- FEI Number: 3006476365
- Address Line 1: Science Park, 2, Snunit St
- City: Karmiel
- Country Name: Israel
- Address: Science Park, 2, Snunit St, Karmiel, Israel
- Country: Israel

## Stock

- Stock ticker: PLX
- Exchange: NYSE
- Share price: $2.96
- Market cap: $249.2M
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 700465 - Protalix Biotherapeutics - 2010-11-11 — classification: No Action Indicated (NAI), source: FDA, date: November 11, 2010